[ Price : $8.95]
FDAs Cardiovascular and Renal Drugs Advisory Committee recommends approval of Daiichi Sankyos once-daily Savaysa (edoxaban) 60 mg ...[ Price : $8.95]
Revive Therapeutics files an IND to FDA for REV-002 (bucillamine) for treating gout.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on the FDA commis...[ Price : $8.95]
Federal Register Notice: FDA corrects a notice on exports and notification and recordkeeping requirements.[ Price : $8.95]
Federal Register Notice: FDA determines that several drug products were not withdrawn from sale for reasons of safety or effective...[ Price : $8.95]
FDA grants final approval to TWi Pharmaceuticals for its ANDA for a generic version of Eisais Aricept, 23 mg to treat Alzheimers d...[ Price : $8.95]
Amgen petitions FDA to require biosimilar applications to include a certification by the applicant that they will provide the refe...[ Price : $8.95]
A Takeda court filing says FDAs approval of Hikma Pharmaceuticals 505(b)(2) application last month for Mitigare (colchicine) was a...